Literature DB >> 7498282

Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin.

Y Sai1, T Okamura, Y Amakata, N Toda.   

Abstract

Responses to angiotensin II, bradykinin and arginine vasopressin were compared in helical strips of canine pulmonary arteries and veins. Angiotensin II contracted the artery but relaxed the vein strip. The artery contraction was augmented by indomethacin and aspirin and was abolished by losartan. The vein relaxation was not affected by endothelium denudation but was abolished by the cyclooxygenase inhibitors, a prostaglandin I2 synthase inhibitor and losartan. The bradykinin-induced artery relaxation was inhibited by endothelium denudation, NG-nitro-L-arginine (L-NA) or indomethacin and abolished by their combined treatment. The vein relaxation produced by bradykinin was endothelium-independent and was abolished by indomethacin. Vasopressin produced a slight relaxation in the arteries, which was abolished by endothelium denudation and L-NA. The vein relaxation produced by vasopressin was abolished by endothelium denudation and combined treatment with L-NA and indomethacin. It may be concluded that (1) activation of angiotensin AT1 receptor subtype in smooth muscle produces contraction and also relaxation due to prostaglandin I2 release; the former predominates over the latter in the artery, whereas only the latter is operative in the vein, (2) the bradykinin-induced relaxation is due to nitric oxide (NO) from the endothelium and prostaglandin I2 from subendothelial tissues in the artery and solely to prostaglandin I2 in the veins, and (3) the vasopressin-induced relaxation is mediated by endothelial NO in the artery, and NO and prostaglandin I2 in the vein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498282     DOI: 10.1016/0014-2999(95)00343-j

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.

Authors:  Evelyn Lechner; Anna Hofer; Rudolf Mair; Werner Moosbauer; Eva Sames-Dolzer; Gerald Tulzer
Journal:  Eur J Pediatr       Date:  2007-01-16       Impact factor: 3.183

2.  Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT1 /bradykinin B2 receptor heterodimerization.

Authors:  Elaine Leocádia Anton; Daniel Fernandes; Jamil Assreuy; José Eduardo da Silva-Santos
Journal:  Br J Pharmacol       Date:  2019-05-13       Impact factor: 8.739

Review 3.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

4.  Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices.

Authors:  Annette D Rieg; Rolf Rossaint; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

Review 5.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

6.  Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study.

Authors:  Amee M Bigelow; Nancy S Ghanayem; Nathan E Thompson; John P Scott; Laura D Cassidy; Katherine J Woods; Ronald K Woods; Michael E Mitchell; Viktor Hraŝka; George M Hoffman
Journal:  Ann Thorac Surg       Date:  2019-08-07       Impact factor: 5.102

7.  Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS.

Authors:  Hae Jin Kim; Ji Hyun Jang; Yin Hua Zhang; Hae Young Yoo; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2019-08-30       Impact factor: 4.458

Review 8.  Clinical review: Vasopressin and terlipressin in septic shock patients.

Authors:  Anne Delmas; Marc Leone; Sébastien Rousseau; Jacques Albanèse; Claude Martin
Journal:  Crit Care       Date:  2004-09-09       Impact factor: 9.097

9.  Age dependency of vasopressin pulmonary vasodilatory effect in rats.

Authors:  Masahiro Enomoto; Jingyi Pan; Yulia Shifrin; Jaques Belik
Journal:  Pediatr Res       Date:  2013-11-20       Impact factor: 3.756

Review 10.  Role of vasopressin in current anesthetic practice.

Authors:  Keun Suk Park; Kyung Yeon Yoo
Journal:  Korean J Anesthesiol       Date:  2017-05-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.